Catherine Klapperich
Boston University, USA

Dr. Klapperich is Professor of Biomedical Engineering at Boston University. She holds appointments in the Department of Mechanical Engineering and in the Division of Materials Science and Engineering. She is also the Scientific Director of the BU Clinical Testing Laboratory. Dr. Klapperich joined BU as an Assistant Professor in 2003 and has built an internationally recognized research program in point of care diagnostics for infectious disease. She invents new technologies that can expand the reach of molecular diagnostics into resource limited settings in the United States and around the World. She has made contributions that enable integrated sample preparation in microfluidic and paper fluidic devices. She has published pre-clinical proof of concept papers for several of these technologies focused on screening for human papilloma virus (HPV), testing for chlamydia and gonorrhea, and HIV viral load monitoring. All of these applications are imperative to improving women’s health. She has demonstrated a point of care test for monitoring of adherence to pre-exposure prophylaxis drugs in high-risk populations.

Her most recent research interest is looking at combining these diagnostic platforms with comprehensive approaches to public and environmental health, in particular in monitoring endocrine disrupting chemicals in the environment at a community level with integrated guidance and feedback to affected communities. She has received funding from the NIH,NSF, DOD, Wallace H. Coulter Foundation, The Bill and Melinda Gates Foundation, Grand Challenges Africa, and others. In 2020, the ongoing SARS-CoV-2 outbreak shifted the focus of the Klapperich Lab and the PDC to testing and developing point of care modalities for COVID-19. Her excellent work in this area and reputation for scientific leadership of complex projects led her to be chosen by the president of Boston University to lead the scale up of campus wide testing and build a new facility on the BU Campus.